Brendan Ffrench

St. James's Hospital
Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity.

CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity.

Journal: Heliyon
Published: June 26, 2022

MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer.

MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer.

Journal: Translational lung cancer research
Published: May 20, 2021

Circulating tumour cell enumeration does not correlate with Miller-Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy.

Circulating tumour cell enumeration does not correlate with Miller-Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy.

Journal: Breast cancer research and treatment
Published: March 24, 2020

Endogenous exosome labelling with an amphiphilic NIR-fluorescent probe.

Endogenous exosome labelling with an amphiphilic NIR-fluorescent probe.

Journal: Chemical communications (Cambridge, England)
Published: June 15, 2018

Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC.

Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC.

Journal: Oncotarget
Published: March 22, 2017

CD10-/ALDH- cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy.

CD10-/ALDH- cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy.

Journal: Cell death & disease
Published: March 16, 2017

MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cells.

MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cells.

Journal: Cell death and differentiation
Published: January 27, 2017

Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention.

Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention.

Journal: Molecular cancer
Published: October 27, 2016

MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype.

MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype.

Journal: Oncotarget
Published: July 28, 2016

Enhanced regulation of cell cycle and suppression of osteoblast differentiation molecular signatures by prostate cancer stem-like holoclones.

Enhanced regulation of cell cycle and suppression of osteoblast differentiation molecular signatures by prostate cancer stem-like holoclones.

Journal: Journal of clinical pathology
Published: March 05, 2015

Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention.

Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention.

Journal: Molecular cancer
Published: July 15, 2014

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.

Journal: PloS one
Published: January 27, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026